Public consultation on interim decisions to amend the Poisons Standard - ACMS, ACCS & Joint ACMS-ACCS November 2025

Overview

Interim decisions regarding substances discussed at the expert advisory meetings. 

This consultation is for interim decisions made in relation to substances that were discussed at the NOVEMBER 2025 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).

Kindly note that the interim decisions published below may differ from the initial proposal. Please read through the proposed interim decisions which can be accessed through the links below and are available on the consultation page for your convenience.

Once you are familiar with the interim decisions, please provide your comments and votes in relation to the interim decision.

The closing date for this consultation is close of business 4 DECEMBER 2026. All submissions received by the deadline will be considered by the delegate before they make a final decision.

The interim decisions under consultation are detailed in the Public notice of interim decisions NOVEMBER 2025 which can be accessed below: 

• Public notice of interim decisions - ACMS#48 , Joint ACMS - ACCS#42, ACCS#41 - November 2025

Substances for which public comment is sought:

ACMS

• ISOTRETINOIN
• EFEPOETIN ALFA
• VITAMIN D

JOINT ACMS-ACCS

• HYDROQUINONE

ACCS

• OXALIC ACID